SNV, a lipophilic superactive VIP analog, acts through cGMP to promote neuronal survival

Peptides

Volumn 20, Issue 5, 1999, Pages 629-633

  Ashur Fabian, Osnat ^a   Perl, Orly ^a   Lilling, Gila ^a   Fridkin, Mati ^b   Gozes, Illana ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Cyclic guanosine monophosphate (cGMP); Enzymeimmunoassays (EIA); Immunocytochemistry; Neuronal survival; Radioimmunoassays (RIA); Stearyl Nle17 VIP (SNV); Vasoactive intestinal peptide (VIP)

Indexed keywords

CYCLIC GMP; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CELL CULTURE; CELL SURVIVAL; CONTROLLED STUDY; DRUG POTENCY; ELECTROIMMUNOASSAY; IMMUNOCYTOCHEMISTRY; NERVE CELL; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CELL SURVIVAL; CELLS, CULTURED; CEREBRAL CORTEX; CYCLIC GMP; NEUROGLIA; NEURONS; NEUROPROTECTIVE AGENTS; RATS; THIONUCLEOTIDES; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0032871180     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(99)00017-0     Document Type: Article

References (37)

1. Ashman D.F., Lipton R., Melicow M.M., Price T.D. Isolation of adenosine 3′,5′-monophosphate and guanosine 3′,5′-monophosphate from rat urine. Biochem Biophys Res Commun. 11:1963;330-334.
2. Ashur-Fabian O., Giladi E., Brenneman D.E., Gozes I. Identification of VIP/PACAP receptors on rat astrocytes using antisense oligodeoxynucleotides. J Mol Neurosci. 9:1997;211-222.
3. Baldino F., Fitzpatrick-McElligott S., Gozes I., Card J.P. Localization of VIP and PHI-27 messenger RNA in rat thalamic and cortical neurons. J Mol Neurosci. 1:1989;199-207.
4. Brenneman D.E., Eiden L.E. Vasoactive intestinal peptide and electrical activity influence neuronal survival. Proc Natl Acad Sci USA. 83:1986;1159-1162.
5. Brenneman D.E., Neale E.A., Foster G.A., Dautremont S.W., Westbrook G.L. Nonneuronal cells mediate neurotrophic action of vasoactive intestinal peptide. J Cell Biol. 104:1987;1603-1610.
6. Brenneman D.E., Westbrook G.L., Fitzgerald S.P., Ennist D.L., Elkins K.L., Ruff M.R., Pert C.B. Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature. 335:1988;639-642.
7. Brenneman D.E., Schultzberg M., Bartfai T., Gozes I. Cytokine regulation of neuronal survival. J Neurochem. 58:1992;454-460.
8. Card J.P., Fitzpatrick-McElligott S., Gozes I., Baldino F. Jr. Localization of vasopressin, somatostatin and VIP messenger RNA in the rat suprachiasmatic nucleus. Cell Tissue Res. 252:1988;307-315.
9. Dawson T.M., Dawson V.L., Solomon H.S. A novel neuronal messenger molecule in brain the free radical nitric oxide . Annals Neurol. 32:1992;297-306.
10. Fauchere J.L., Chateon M., Kier L.B., Verloop A., Pliska V. Amino acid side parameters for correlation studies in biology and pharmacology. J Peptide Protein Res. 32:1988;269-278.
11. Farinelli S.E., Park D.S., Greene L.A. Nitric Oxide delays the death of trophic factor-deprived PC12 cells and sympathetic neurons by a cGMP-mediated mechanism. J Neurosci. 16:(7):1996;2325-2334.
12. Forsythe I.D., Westbrook G.L. Slow excitatory postsynaptic currents mediated by N-methyl-D-aspartate receptors on cultured mouse central neurons. J Physiol. 396:1988;515-533.
13. Gonzales J.M., Loeb A.L., Reichard P.S., Irvine S. Ketamine inhibits glutamate-,N-methyl-D-aspartate-, and quisqualate-stimulated cGMP production in cultured cerebral neurons. Anesthesiology. 82:(1):1995;205-213.
14. Gourlet P., De Neef P., Cnudde J., Waelbroeck M., Robberecht P. In vitro properties of a high affinity selective antagonists of the VIP1 receptor. Peptides. 18:(10):1997;1555-1560.
15. Gourlet P., Vandermeers A., Vertongen P., Rathe J., De Neef P., Cnudde J., Waelbroeck M., Robberecht P. Development of high affinity selective VIP1 receptor agonists. Peptide. 18:(10):1997;1539-1545.
16. Gozes I., Brenneman D.E. VIP- molecular biology and neurobiological function. Molecular Neurobiol. 3:1989;201-225.
17. Gozes I., McCune S.K., Jacobson L., Warren D., Moody T.W., Fridkin M., Brenneman D.E. An antagonist to vasoactive intestinal peptide effect on cellular function in the central nervous system . J Pharmacol Exp Therap. 257:1991;959-966.
18. Gozes I., Fridkin M. A fatty neuropeptide potential drug for non-invasive impotence treatment in rat model . J Clin Invest. 90:1992;810-814.
19. Gozes I., Glowa J., Brenneman D.E., Mccune S.K., Lee E., Westphal H. Learning and sexual deficiencies in transgenic mice carrying chimeric vasoactive intestinal peptide gene. J Molec Neurosci. 4:1993;185-193.
20. Gozes I., Reshef A., Salah D., Rubinraut S., Fridkin M. Stearyl-norleucine-VIP, a novel VIP analogue for non-invasive impotence treatment. Endocrinology. 134:1994;2121-2125.
21. Gozes I., Lilling G., Glazer R., Ticher A., Ashkenazi I.E., Davidson A., Rubinraut S., Fridkin M., Brenneman D.E. Superactive lipophilic peptides discriminate multiple vasoactive intestinal peptide receptors. J Pharmacol Exp Therap. 273:1995;161-167.
22. Gozes I., Bardea A., Reshef A., Zamostiano R., Zhukovsky S., Rubinraut S., Fridkin M., Brenneman D.E. Neuroprotective strategy for Alzheimer disease intranasal administration of a fatty neuropeptide . Proc Natl Acad Sci. 93:1996;427-432.
23. Gozes I., Bachar M., Bardea A., Davidson A., Rubinraut S., Fridkin M., Giladi E. Protection against developmental retardation in apolipoprotein E-deficient mice by a fatty neuropeptide implication for early treatment of Alzheimer disease . J Neurobiol. 33:1997;329-342.
24. Gozes I., Davidson A., Gozes Y., Mascolo R., Barth R., Warren D., Hauser J., Brenneman D.E. Antiserum to activity-dependent neurotrophic factor produces neuronal cell death in CNS cultures immunological and biological specificity . Developmental Brain Res. 99:1997;167-175.
25. Gressens P., Hill J.M., Gozes I., Fridkin M., Brenneman D.E. Growth factor function of vasoactive intestinal peptide in whole cultured mouse embryos. Nature. 362:1993;155-158.
26. Ho A.K., Chik C.L., Klein D.C. Transmembrane receptor cross talk concurrent VIP and alpha 1-Adranergic activation rapidly elevates pinealocyte cGMP greater than 100-fold . Biochem Biophys Res Commun. 146:1987;1478-1484.
27. Lilling G., Wollman Y., Goldstein M.N., Rubinraut S., Fridkin M., Brenneman D.E., Gozes I. Inhibition of human neuroblastoma growth by a specific VIP antagonist. J Molec Neurosci. 5:1995;231-239.
28. 2+/calmodulin-stimulated cGMP phosphodiesterase as components of neuronal signal transduction. Advanced in Second Messenger and Phosphoprotein Res. 28:1993;111-119.
29. Magistretti P.J., Schorderet M. VIP and noradrenaline act synergistically to increase cyclic AMP in cerebral cortex. Nature. 308:1984;280-282.
30. McCarthy K.D., De Vellis J. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol. 85:1980;890-902.
31. Mitka M. Viagra leads as rivals are moving up. JAMA. 280:1998;119-120.
32. Ogiwara T., Murdoch G., Chik C.L., Ho A.K. Tyrosine kinase inhibitors enhance cGMP production in rat pinealocytes. Biochem Biophys Res Commun. 207:1995;994-1002.
33. Roskovski R. Jr, Vulliet R., Glass D.B. Phosphorylation of tyrosine hydroxylase by cyclic GMP-dependent protein kinase. J Neurochem. 48:1987;840-845.
34. Romijn H.J., Habets A.M.M.C., Mud M.T., Wolters P.S. Nerve outgrowth, synaptogenesis and bioelectric activity in fetal rat cerebral cortex tissue cultured in serum free chemically defined medium. Dev Brain Res. 2:1982;583-589.
35. Schaad N.S., Vanecek J., Rodriguez I.R., Klein D.C., Holtzclaw L., Russel J.T. Vasoactive intestinal peptide elevates pinealocyte intracellular calcium concentration by enhancing influx evidence for involvement of a cyclic GMP-dependent mechanism . Molec Pharm. 47:1995;923-933.
36. Schmechel DE, Marangos PJ. Current methods in cellular neurobiology. Barker JL, McKelvy JR, Eds. vol. 1. Wiley Interscience: 1983:1-62.
37. Vertongen P., Schiffman S.N., Gourlet P., Robberecht P. Autoradiographic visualization of the receptor subclasses for vasoactive intestinal polypeptide (VIP) in rat brain. Peptides. 18:(10):1997;1547-1554.